ADAR and cancer: In conclusion, we have identified ADAR1i-124, the first and effective ADAR1 inhibitor, and demonstrated its promise for use as a powerful tool to investigate the multi-faceted functions of ADAR1 and also as the basis for a future therapeutic to treat cancers and immunotherapy resistance.